Extended Use of The Spanner® Temporary Prostatic Stent in Catheter-Dependent Men with Comorbidities
Table 2
Characteristics at enrollment.
Mean ± SD, median, Min-Max, n
Demographics
Age (years)
77.1 ± 10.6, 78, 50–97, 107
BMI
27.6 ± 5.5, 27, 19–50, 102
Catheter type
n/N (%)
Foleyi
63/107 (58.9%)
Intermittenti
40/107 (37.4%)
Unconfirmed catheter type
6/107 (5.6%)
Bladder health
Trabeculation
64/107 (60.0%)
Cystitis
11/107 (10.3%)
Diverticulum
22/107 (20.6%)
Medical history
Genitourinary other than urinary retention
90/107 (84.1%)
Cardiovascular
88/107 (82.2%)
Endocrine/metabolic
69/107 (64.5%)
Medical and surgical procedures
50/107 (46.7%)
Gastrointestinal
41/107 (38.3%)
Musculoskeletal
30/107 (28.0%)
Psychiatric
28/107 (26.2%)
Neurological
18/107 (16.8%)
Respiratory
18/107 (16.8%)
HEENT (head, eyes, ears, nose, and throat)
14/107 (13.1%)
Hematologic/lymphatic
14/107 (13.1%)
Allergic/immunologic
9/107 (8.4%)
Dermatological
4/107 (3.7%)
Substance abuse
4/107 (3.7%)
General
1/107 (0.9%)
Baseline data for all enrolled patients including medical history categorized by Charlson Comorbidity Index. iTwo patients reported both Foley and intermittent catheter use and are included in both groups.